Whether you’re in the biopharma industry or not, you’ve heard about the controversy surrounding the pricing of Sovaldi and Harvoni, two therapies for hepatitis C that have revolutionized the treatment of a very common and sometimes deadly disease. The topic first came up when Sovaldi was launched December 2013, but the noise still hasn’t died down […]
Trending Articles
More Pages to Explore .....